Toptal boosts pharmaceutical risk management for infant formula maker and reduces waste by 60%.

A major infant formula manufacturer turned to Toptal amid an FDA-related shutdown to address contamination concerns and improve microbiological risk management.

Client

A global healthcare company producing affordable over-the-counter and self-care products for consumers worldwide.

Employees

8,900+

Revenue

$4.4B

Industry

Healthcare and Life Sciences

Delivered Services

Get a free consultation now

Schedule a Call

Challenge

The regulatory crisis presented operational challenges, requiring enhanced microbiological risk management practices as outdated processes hindered compliance with safety regulations.

Solution

Agile Project Implementation

Toptal deployed experienced Agile project managers to implement Scrum methodologies across all locations, fostering rapid problem-solving and ensuring a comprehensive project plan for enhanced sanitation practices.

Comprehensive Risk Strategies

Toptal introduced systematic change management strategies, including national process improvement projects and training programs, establishing a foundation for long-term compliance sustainability.

Outcome

Operational Excellence Restored

The implementation led to all product releases occurring without delays and a 60% reduction in waste, reinstating confidence in manufacturing capabilities and relationships with regulators.

Increased Employee Satisfaction

The initiatives led to a 42% increase in employee satisfaction and improved communication across departments, reinforcing compliance and proactive risk management.

Share

Get a free consultation now

Schedule a Call